💊 Hydroxychloroquine Dose Reference

Hydroxychloroquine dosing follows a weight-based ceiling: no more than 5 mg/kg/day of actual body weight, so a 70 kg adult caps at 350 mg/day (practically 200-400 mg daily as prescribed). Enter weight for the ceiling and the practical tablet math.

How to Use This Reference

This summarizes standard rheumatology dosing and the American Academy of Ophthalmology screening guidance. It is educational; your rheumatologist sets the dose.

The 5 mg/kg Rule

The ceiling exists because of retinopathy: risk climbs with daily dose per kilogram and cumulative exposure, and the 2016 AAO guidelines moved from the old 6.5 mg/kg ideal-weight rule to 5 mg/kg actual weight after data showed the old rule overdosed small patients. At ≤5 mg/kg, retinopathy risk stays under ~2% in the first decade; above it, risk rises steeply. Most adults land on 200-400 mg daily: a 70 kg patient's 350 mg ceiling usually becomes 200 mg daily or 400 mg on alternating schedules per prescriber judgment. Underdosing has its own cost in lupus: the drug reduces flares, clots, diabetes, and mortality, so the goal is the right dose, not the smallest.

Worked Example

70 kg: ceiling 350 mg/day; practical 200 mg daily (some prescribers use 200/400 alternating to average 300). 55 kg: ceiling 275 mg/day; practical 200 mg daily. 90 kg: ceiling 450 mg/day; practical 400 mg daily (the de facto cap). Short patient, 50 kg: ceiling 250 mg/day: this is where the weight rule bites, because the old "400 mg for everyone" habit would overdose her by 60%. The calculator shows the ceiling and tablet math. Blood levels can adjudicate adherence vs absorption when response is poor: whole-blood levels under ~500 ng/mL suggest nonadherence more often than treatment failure.

What It Treats

Lupus is the headline: guidelines recommend hydroxychloroquine for essentially every SLE patient without contraindication, continued through pregnancy (it improves outcomes) and flares. It takes 2-3 months to reach full effect, which is why it backgrounds faster-acting drugs rather than replacing them. For autoimmune context, our GFR calculator matters because lupus nephritis dosing and monitoring run through the kidneys, and our fatigue scale tracks a cardinal lupus symptom.

Retinal Screening: The Main Risk

Hydroxychloroquine retinopathy is the serious toxicity: bull's-eye maculopathy that is irreversible once symptomatic, hence screening, not symptom-watching. Schedule: baseline fundus exam within the first year (to rule out pre-existing maculopathy), then annual screening after 5 years with automated visual fields plus spectral-domain OCT (the sensitive pair). High-risk patients (high dose, CKD, tamoxifen use, pre-existing macular disease) start annual screening sooner. Risk factors stack: dose >5 mg/kg, duration >5 years, kidney impairment (reduced clearance), and tamoxifen. Report visual changes (reading difficulty, missing spots, color vision shifts) promptly whenever they occur.

Other Safety Notes

QT prolongation: modest risk alone, meaningful combined with other QT drugs (azithromycin, the combination that caused harm in COVID trials). Hypoglycemia: the drug lowers glucose; diabetics may need less medication. Myopathy and cardiomyopathy are rare but real with long use; new muscle weakness or heart failure symptoms deserve evaluation. Skin: rashes and pigment changes occur; smoking reduces cutaneous efficacy. G6PD deficiency: hemolysis risk is low with hydroxychloroquine (unlike primaquine) but screening is still commonly done. Take with food to reduce nausea, and never adjust the dose without your rheumatologist: the ceiling is theirs to apply.

Adherence: The Hidden Variable

Hydroxychloroquine nonadherence is remarkably common (studies find a third or more of lupus patients under-dosed by behavior, not prescription), and it masquerades as treatment failure. The drug's 40-day half-life is forgiving of occasional misses but not of pattern nonadherence, and its slow onset means patients quit before benefit arrives. Whole-blood hydroxychloroquine levels settle the question: under ~500 ng/mL suggests missed doses, therapeutic ranges run ~500-2000, and very high levels flag overdosage risk. Flares in a "non-responder" with low blood levels are an adherence problem, not a drug problem. Practical aids: tie dosing to an existing habit (with breakfast), use a weekly pill organizer, and understand the timeline (2-3 months to full effect) before judging. If side effects drive the skipping, report them: nausea often yields to timing and food adjustments rather than abandonment.

For informational purposes only, not medical advice. Consult a healthcare professional.